The Short-Term Effect of a Single Lapse in Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular EdemaWithin Routine Clinical Practice

Diabetic macular edema (DME) is a leading cause of vision loss in diabetics. Anti-vascular endothelial growth factor (VEGF) therapy has been shown to be an effective treatment option for DME, although the injections are costly and require frequent visits which increases the risk for unintended treatment lapses. The aim of this study is to characterize the effects of an unintended treatment lapse in patients with DME undergoing anti-VEGF therapy.

Source: American Journal of Ophthalmology - July 3, 2020 Category: Opthalmology Authors: Siri P. Yalamanchili, Christopher M. Maatouk, Daniel U. Enwere, Thais F. Conti, Grant L. Hom, Isaac N. Briskin, Tyler E. Greenlee, Amy S. Babiuch, Rishi P. Singh Tags: Original Articles Source Type: research